🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Mesalazine - Medicines in Ireland

41 authorised products containing Mesalazine, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 41 authorised medicines
MedicineActive substanceLicence holderStatus
Asacolon 1000 mg Suppository
PA2018/005/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 1600 mg modified-release tablets
PA2018/004/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 400mg Gastro-Resistant Tablets
PA2018/001/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 500 mg Suppositories
PA2018/001/003
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 800 mg Gastro-resistant Tablets
PPA0465/465/001
Mesalazine PCO Manufacturing Ltd.
Asacolon 800mg Gastro-resistant Tablets
PA2018/001/002
Mesalazine Tillotts Pharma GmbH Marketed
Galtasa 1000 mg gastro-resistant tablets
PA0864/001/003
Mesalazine Faes Farma S.A. Not marketed
Galtasa 500 mg gastro-resistant tablets
PA0864/001/001
Mesalazine Faes Farma S.A. Not marketed
Galtasa 500 mg suppositories
PA0864/001/002
Mesalazine Faes Farma S.A. Not marketed
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PA23211/004/001
Mesalazine Takeda Pharmaceuticals International AG Ireland Branch Marketed
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA0465/289/001
Mesalazine PCO Manufacturing Ltd.
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA1463/093/001
Mesalazine IMED Healthcare Ltd.,
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA2306/023/001
Mesalazine Originalis B.V.
Pentasa 1 g prolonged-release tablets
PA1009/006/007
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1 g prolonged-release tablets
PPA1463/110/002
Mesalazine IMED Healthcare Ltd.
Pentasa 1 g prolonged-release tablets
PPA0465/450/003
Mesalazine PCO Manufacturing Ltd.
Pentasa 1 g suppositories
PPA2306/010/001
Mesalazine Originalis B.V.
Pentasa 1 g Suppositories
PPA1463/190/003
Mesalazine IMED Healthcare Ltd.,
Pentasa 10 mg/ml Rectal Suspension
PA1009/006/003
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PA1009/006/002
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PPA0465/450/005
Mesalazine PCO Manufacturing Ltd.
Pentasa 500 mg prolonged-release tablets
PA1009/006/005
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 500 mg prolonged-release tablets
PPA1463/110/001
Mesalazine IMED Healthcare Ltd.,
Pentasa Sachet 1g prolonged-release granules
PA1009/006/001
Mesalazine Ferring Ireland Ltd Marketed
Pentasa Sachet 1g prolonged-release granules
PPA0465/450/006
Mesalazine PCO Manufacturing Ltd.
Pentasa Sachet 2 g prolonged-release granules
PPA0465/450/001
Mesalazine PCO Manufacturing Ltd.
Pentasa Sachet 2 g prolonged-release granules
PPA1463/190/001
Mesalazine IMED Healthcare Ltd.,
Pentasa Sachet 2g prolonged-release granules
PA1009/006/006
Mesalazine Ferring Ireland Ltd Marketed
Pentasa Sachet 2g prolonged-release granules
PPA2306/010/002
Mesalazine Originalis B.V.
Pentasa Sachet 4 g prolonged-release granules
PPA0465/450/004
Mesalazine PCO Manufacturing Ltd.
Pentasa Sachet 4 g prolonged-release granules
PPA1463/190/002
Mesalazine IMED Healthcare Ltd.,
Pentasa Sachet 4 g Prolonged-release granules
PA1009/006/008
Mesalazine Ferring Ireland Ltd Marketed
Salofalk 1.5g prolonged-release granules
PA0573/003/007
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1000mg prolonged-release granules
PA0573/003/002
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1g Suppositories
PA0573/004/004
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1g Suppositories
PPA1463/212/001
Mesalazine IMED Healthcare Ltd.,
Salofalk 1g/Actuation Rectal Foam
PA0573/004/005
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 250 mg Suppositories
PA0573/004/002
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 3g prolonged-release granules
PA0573/003/006
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 4g/60ml Enema
PA0573/004/001
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 500 mg prolonged-release granules
PA0573/003/001
Mesalazine Dr. Falk Pharma GmbH Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.